Labeled for this condition

Medicines for type 2 diabetes

52 medicines have an FDA label indicated for type 2 diabetes; 24 are listed from generic labelers and 1 has a presentation in shortage now (FDA files, October 8, 2026).

Which medicines are labeled for type 2 diabetes?

Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.

Recalls: FDA enforcement reports, 2012 on
Medicine	Brand names	Generic labelers (all forms)	Pharmacy cost	Boxed warning	Shortage	Recalls since 2012
Metformin	Glumetza, Riomet	80 labelers	$0.0145 per tablet 500 mg tablet	Yes	No current entry	61
Glipizide	Glucotrol	31 labelers	$0.0339 per tablet 5 mg tablet	No	No current entry	9
Glimepiride	none listed	27 labelers	$0.0507 per tablet 4 mg tablet	No	No current entry	19
Pioglitazone	Actos	22 labelers	$0.0675 per tablet 15 mg tablet	Yes	No current entry	2
Glyburide	none listed	16 labelers	$0.0643 per tablet 5 mg tablet	No	A presentation being discontinued	0
Tirzepatide	Mounjaro, Zepbound	none listed	$538.68 per mL 10 mg/0.5 mL pen	Yes	No current entry	0
Dapagliflozin	Farxiga	22 labelers	$0.184 per tablet 10 mg tablet	No	No current entry	0
Dapagliflozin and metformin	Xigduo	8 labelers	$0.720 per tablet 10-1,000 mg tablet	Yes	No current entry	2
Metformin and sitagliptin	Zituvimet, Janumet	4 labelers	$1.76 per tablet 50 mg-1,000 mg tablet	Yes	No current entry	1
Sitagliptin	Januvia, Zituvio, Brynovin	4 labelers	$3.77 per tablet 100 mg tablet	No	No current entry	1
Insulin aspart	Novolog, Fiasp, Kirsty	none listed	$6.95 per mL 100 unit/mL vial	No	No current entry	5
Colesevelam	none listed	15 labelers	$0.262 per tablet 625 mg tablet	No	No current entry	1
Glyburide and metformin	Glyburide-Metformin	11 labelers	$0.171 per unit 2.5-500 mg	Yes	No current entry	1
Insulin lispro	Humalog, Lyumjev, Admelog	none listed	$10.19 per mL 100 unit/mL kwikpen	No	A presentation being discontinued	4
Semaglutide	Wegovy, Ozempic, Rybelsus	none listed	$331.99 per mL 0.25-0.5 mg/dose (2 mg/3 mL) pen	Yes	A presentation being discontinued	4
Insulin human	Humulin, Novolin, Afrezza	none listed	$4.26 per mL 70-30 vial	No	No current entry	1
Insulin glargine	Lantus, Toujeo, Semglee	none listed	$2.90 per mL 100 pen	No	A presentation being discontinued	2
Glipizide and metformin	none listed	9 labelers	$0.242 per unit 2.5-250 mg	No	No current entry	1
Liraglutide	Victoza, Saxenda	9 labelers	$31.41 per mL 2-pak 18 mg/3 mL	Yes	In shortage	3
Repaglinide	none listed	7 labelers	$0.0987 per tablet 1 mg tablet	No	No current entry	0
Nateglinide	none listed	9 labelers	$0.179 per tablet 60 mg tablet	No	No current entry	0
Acarbose	none listed	6 labelers	$0.274 per tablet 100 mg tablet	No	No current entry	2
Metformin and pioglitazone	Actoplus	5 labelers	$0.283 per unit 15-500	Yes	No current entry	1
Dulaglutide	Trulicity	none listed	$487.57 per mL 0.75 mg/0.5 mL pen	Yes	No current entry	2
Empagliflozin	Jardiance	none listed	$11.19 per tablet 10 mg tablet	No	No current entry	2
Alogliptin	Nesina	none listed	$4.96 per tablet 12.5 mg tablet	No	No current entry	0
Bromocriptine	Cycloset	6 labelers	$1.61 per tablet 2.5 mg tablet	No	No current entry	5
Insulin degludec	Tresiba	none listed	$11.39 per mL 100 unit/mL pen	No	No current entry	3
Alogliptin and pioglitazone	Oseni	none listed	$4.73 per tablet 25-15 mg tablet	Yes	No current entry	0
Canagliflozin and metformin	Invokamet	none listed	$9.58 per tablet 150-1,000 mg tablet	Yes	No current entry	1
Empagliflozin and metformin	Synjardy	none listed	$5.60 per tablet 12.5-1,000 mg tablet	Yes	No current entry	4
Linagliptin and metformin	Jentadueto	1 labeler	$8.44 per tablet 2.5 mg-1,000 mg tablet	Yes	No current entry	1
Canagliflozin	Invokana	none listed	$19.13 per tablet 100 mg tablet	No	No current entry	0
Metformin and saxagliptin	none listed	2 labelers	$9.65 per tablet 5-1,000 mg tablet	Yes	No current entry	0
Miglitol	none listed	2 labelers	n/a	No	No current entry	0
Saxagliptin	none listed	3 labelers	$1.04 per tablet 5 mg tablet	No	No current entry	2
Alogliptin and metformin	Kazano	none listed	$2.46 per unit 12.5-1000	Yes	No current entry	0
Empagliflozin and linagliptin and metformin	Trijardy	none listed	$11.28 per tablet 10-5-1,000 mg tablet	Yes	No current entry	0
Ertugliflozin and metformin	Segluromet	none listed	$5.76 per tablet 2.5-1,000 mg tablet	Yes	No current entry	0
Exenatide	Byetta	1 labeler	$300.17 per mL 10 mcg dose pen injection	No	No current entry	1
Glimepiride and pioglitazone	Duetact	none listed	$10.52 per unit 30-4	Yes	No current entry	1
Bexagliflozin	Brenzavvy	none listed	n/a	No	No current entry	0
Linagliptin	Tradjenta	none listed	$16.80 per tablet 5 mg tablet	No	No current entry	0
Empagliflozin and linagliptin	Glyxambi	none listed	$11.24 per tablet 10 mg-5 mg tablet	No	No current entry	1
Ertugliflozin	Steglatro	none listed	$11.44 per tablet 15 mg tablet	No	No current entry	1
Ertugliflozin and sitagliptin	Steglujan	none listed	$17.59 per tablet 15-100 mg tablet	No	No current entry	0
Insulin glulisine	Apidra	none listed	$8.16 per mL 100 unit/mL vial	No	No current entry	0
Pramlintide	Symlinpen	none listed	n/a	Yes	A presentation being discontinued	0
Dapagliflozin and saxagliptin	none listed	1 labeler	n/a	No	No current entry	0
Insulin degludec and liraglutide	Xultophy	none listed	$85.89 per mL 100 unit-3.6 mg/mL pen	Yes	No current entry	1
Insulin detemir	Levemir	none listed	n/a	No	No current entry	0
Insulin glargine and lixisenatide	Soliqua	none listed	$57.06 per mL 100 unit-33 mcg/mL pen	No	No current entry	0

Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Every condition
Compare two medicines